Thomson Medical Group (FRA:3H5) ROE %: -4.25% (As of Dec. 2025)


What is Thomson Medical Group ROE %?

Thomson Medical Group FRA:3H5 ROE % is -4.25% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 625 Healthcare Providers & Services companies, Thomson Medical Group ranks worse than 77.92% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Thomson Medical Group's annualized net income for the quarter that ended in Dec. 2025 was €-13.6 Mil. Thomson Medical Group's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was €319.1 Mil. Therefore, Thomson Medical Group's annualized ROE % for the quarter that ended in Dec. 2025 was -4.25%.

The historical rank and industry rank for Thomson Medical Group's ROE % or its related term are showing as below:

FRA:3H5' s ROE % Range Over the Past 10 Years
Min: -11.82   Med: 1.35   Max: 18.41
Current: -9.19

During the past 13 years, Thomson Medical Group's highest ROE % was 18.41%. The lowest was -11.82%. And the median was 1.35%.

FRA:3H5's ROE % is ranked worse than
77.92% of 625 companies
in the Healthcare Providers & Services industry
Industry Median: 5.84 vs FRA:3H5: -9.19

Thomson Medical Group  (FRA:3H5) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-13.558/319.1485
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-13.558 / 281.964)*(281.964 / 1193.0845)*(1193.0845 / 319.1485)
=Net Margin %*Asset Turnover*Equity Multiplier
=-4.81 %*0.2363*3.7383
=ROA %*Equity Multiplier
=-1.14 %*3.7383
=-4.25 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=-13.558/319.1485
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-13.558 / -7.976) * (-7.976 / 24.066) * (24.066 / 281.964) * (281.964 / 1193.0845) * (1193.0845 / 319.1485)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.6998 * -0.3314 * 8.54 % * 0.2363 * 3.7383
=-4.25 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Thomson Medical Group ROE % Related Terms

Thomson Medical Group ROE % Historical Data

* Premium members only.

The historical data trend for Thomson Medical Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thomson Medical Group ROE % Chart

Thomson Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Jun21 Jun22 Jun23 Jun24 Jun25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 11.00 7.10 2.84 -9.72

Thomson Medical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 4.92 -5.18 -13.79 -4.25

FRA:3H5 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Thomson Medical Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thomson Medical Group ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Thomson Medical Group's ROE % distribution charts can be found below:

* The bar in red indicates where Thomson Medical Group's ROE % falls into.


Thomson Medical Group ROE % Calculation

Thomson Medical Group's annualized ROE % for the fiscal year that ended in Jun. 2025 is calculated as

ROE %=Net Income (A: Jun. 2025 )/( (Total Stockholders Equity (A: Jun. 2024 )+Total Stockholders Equity (A: Jun. 2025 ))/ count )
=-32.162/( (343.45+318.336)/ 2 )
=-32.162/330.893
=-9.72 %

Thomson Medical Group's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=-13.558/( (318.336+319.961)/ 2 )
=-13.558/319.1485
=-4.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -4.25% mean?
Thomson Medical Group (FRA:3H5) has a ROE % of -4.25% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Thomson Medical Group and its competitors. According to the industry distribution chart, Thomson Medical Group ranks #487 out of 625 companies in the Healthcare Providers & Services industry, placing it in the top 77.9%.
Is Thomson Medical Group's ROE % too high?
Thomson Medical Group's current ROE % is -4.25%. Based on the distribution chart, Thomson Medical Group ranks #487 out of 625 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Thomson Medical Group's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Thomson Medical Group ranks #487 out of 625 companies for ROE %. This places Thomson Medical Group in the lower half of its industry. The industry median ROE % is 5.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.84, based on 625 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Thomson Medical Group and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thomson Medical Group's current ROE % is -4.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thomson Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Thomson Medical Group (FRA:3H5) is currently considered Possible Value Trap. The stock's GF Value™ is €0.05, compared to a current price of €0.04 — trading 30% below its estimated fair value. The current ROE % is -4.25%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Thomson Medical Group (FRA:3H5), the current ROE % is -4.25% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Thomson Medical Group Business Description

Other Exchanges A50:Singapore
Address 101 Thomson Road, No. 20-04/05, United Square, Singapore, SGP, 307591
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore.